Clinical Trial Update: O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 trial evaluating O6-benzylguanine in combination with Carmustine in children with refractory brain and central n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Cancer
• Central Nervous System Tumors

Drugs mentioned

• Carmustine (carmustine)
• O6-Benzylguanine (O6-Benzylguanine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Brain and Central Nervous System Tumors | Phase 1 | Status: COMPLETED